ADVFN - Advanced Financial Network.
HOME» NYSE » D » DVA Stock Price » DVA Stock News

Davita Share News

 Davita Inc. Stock Price
DVA Stock Price
 Davita Inc. Stock Chart
DVA Stock Chart
 Davita Inc. Stock News
DVA Stock News
 Davita Inc. Company Information
DVA Company Information
 Davita Inc. Stock Trades
DVA Stock Trades

DaVita Agrees to $55 Million Settlement

DaVita Inc. (DVA) agreed to pay roughly $55 million in a settlement of a lawsuit filed by an individual in 2002 related to the anemia drug Epogen. The dialysis-service provider said the agreement, which also includes the payment of attorneys fees, contains no findings of wrongdoing or admission of liability by the company. "DaVita and its affiliated physicians did nothing wrong and stand by their anemia management practices," the company said. In a previous SEC filing, the company identified the individual as Ivey Woodard and said it was served with a complaint under the qui tam provisions of the federal False Claims Act. DaVita also said the government investigated allegations raised by the individual; however, it chose not to file claims against DaVita. DaVita's shares closed at $97.62 on Monday and were inactive premarket. The stock is up 29% year-to-date. Write to Saabira Chaudhuri at

Stock News for Davita (DVA)
11/24/201506:22:00DaVita Kidney Care Offers Fall Favorites Cookbook
11/18/201517:13:27Current Report Filing (8-k)
11/12/201517:54:53Statement of Changes in Beneficial Ownership (4)
11/06/201506:48:00Recipients of Bio-specimen Grant Program BioReG Announced During...
11/05/201507:22:56Quarterly Report (10-q)
11/03/201516:18:52Current Report Filing (8-k)
11/03/201516:03:00DaVita HealthCare Partners Inc. 3rd Quarter 2015 Results
10/29/201506:13:00Kidney-Friendly Tips and Treats for Halloween
10/23/201518:36:33Young And Cautious Portfolio - One Month On
10/20/201506:12:00DaVita HealthCare Partners Inc. Schedules 3rd Quarter 2015 Investor...
10/12/201506:13:00DaVita to Expand World Headquarters in Downtown Denver
10/09/201518:45:35Initial Statement of Beneficial Ownership (3)
10/09/201506:03:02Current Report Filing (8-k)
10/08/201517:22:00Barbara Allen Named Chief Medical Officer of JSA Medical Group
10/08/201516:35:00DaVita is Clinical Leader in Government Five-Star Ratings
10/08/201506:00:00DaVita Appoints Barbara J. Desoer to Board of Directors
10/07/201516:35:00DaVita Kidney Care Launches the First Ever Medicare Disease-Specific...
10/07/201516:35:00DaVita Kidney Care Launches the Only Medicare Disease-Specific...
10/07/201516:35:00DaVita Kidney Care Launches the First Ever Medicare Disease-Specific...
10/07/201516:32:00DaVita Kidney Care Launches the First Ever Medicare Disease-Specific...

Davita and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations